These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16339302)

  • 1. Serologic markers in inflammatory bowel disease.
    Bossuyt X
    Clin Chem; 2006 Feb; 52(2):171-81. PubMed ID: 16339302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relevance of serologic studies in inflammatory bowel diseases].
    Papp M; Altorjay I; Lakatos PL
    Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of serologic studies in inflammatory bowel disease.
    Vernier G; Sendid B; Poulain D; Colombel JF
    Curr Gastroenterol Rep; 2004 Dec; 6(6):482-7. PubMed ID: 15527678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
    Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
    World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
    Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic markers in inflammatory bowel disease: state of the art.
    Sandborn WJ
    Rev Gastroenterol Disord; 2004; 4(4):167-74. PubMed ID: 15580151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.
    Kovacs M; Lakatos PL; Papp M; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Muller KE; Molnar K; Szabo D; Cseh A; Dezsofi A; Arato A; Veres G
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):429-35. PubMed ID: 22465933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in clinical laboratory tests for inflammatory bowel disease.
    Nakamura RM; Matsutani M; Barry M
    Clin Chim Acta; 2003 Sep; 335(1-2):9-20. PubMed ID: 12927679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody markers in the diagnosis of inflammatory bowel disease.
    Mitsuyama K; Niwa M; Takedatsu H; Yamasaki H; Kuwaki K; Yoshioka S; Yamauchi R; Fukunaga S; Torimura T
    World J Gastroenterol; 2016 Jan; 22(3):1304-10. PubMed ID: 26811667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.
    Sura SP; Ahmed A; Cheifetz AS; Moss AC
    J Clin Gastroenterol; 2014 Apr; 48(4):351-5. PubMed ID: 24492405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic testing for inflammatory bowel disease.
    Hoffenberg EJ; Fidanza S; Sauaia A
    J Pediatr; 1999 Apr; 134(4):447-52. PubMed ID: 10190919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
    Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
    Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
    Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center.
    Gupta A; Derbes C; Sellin J
    Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG; Kim YS; Kim JS; Jung HC; Song IS
    Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.